Business Context and Reporting Period
This Form 6-K filing by MediWound Ltd. covers the month of June 2018. The document reports on the Company's Annual General Meeting of Shareholders held on June 18, 2018, in Yavne, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this filing. The document details the successful approval of four shareholder proposals that were previously described in the proxy statement filed on May 10, 2018.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It confirms that a quorum was present, with 17,123,063 shares (63.3% of outstanding shares) represented at the meeting, and that all four proposals were approved under Israeli Companies Law.
Investor Verification Checklist
- Verify the specific details of the four approved proposals in the proxy statement filed on May 10, 2018 (Exhibit 99.1).
- Confirm the total number of ordinary shares issued and outstanding as of the record date (27,047,737).
- Review the Company's Form 20-F for the most recent audited financial statements, as this 6-K contains no financial data.